Medical experts say there are at least 14 lesser-known symptoms of lung cancer people can look out for. Many are very rare, ...

Cava Group (NYSE: CAVA) shareholders are sitting fat and happy after the last year. As of this writing the stock in the Mediterranean restaurant chain is up a whopping 300% in the last 12 months ...

Financial giants have made a conspicuous bearish move on Cava Group. Our analysis of options history for Cava Group (NYSE:CAVA) revealed 11 unusual trades. Delving into the details, we found 18% ...

Like Chipotle, Cava is growing its same-restaurant sales at a strong pace. Both restaurant operators have efficient models that lead to impressive restaurant-level margins. Expansion is Cava's ...

A multimodal approach for the treatment of upper extremity thrombosis, developed by Machleder, [14] was adopted in the patient, and proved to be successful.

In 2022, Dion announced that she was diagnosed with stiff person syndrome, a rare neurological disorder that causes muscle spasms and impacts her ability to sing. At the time, Dion canceled all of ...

Cava Group's stock has been red-hot since its IPO in June 2023. By mid-2024, Cava had expanded to nearly 350 locations, with plans for over 50 new openings in 2024. Cava's same-store sales are ...

The most recent trading session ended with Cava Group (CAVA) standing at $126.84, reflecting a -0.47% shift from the previouse trading day's closing. This change lagged the S&P 500's daily loss of ...

CAVA Group, Inc.‘s CAVA shares are trading at a substantial premium, far outpacing the Zacks Retail-Restaurant industry. With a forward 12-month Price-to-Sales ratio of 13.49x, CAVA dwarfs the ...

What is Lambert-Eaton syndrome? Lambert-Eaton syndrome is also known as Lambert-Eaton myasthenic syndrome. It is a rare, autoimmune disorder in which the immune system attacks the neuromuscular ...